Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models

European Journal of Pharmacology

Volumn 390, Issue 1-2, 2000, Pages 203-207

  Fukuda, Yoshiaki ^a   Kawashima, Hiroshi ^a   Saito, Kayo ^a   Inomata, Norio ^a   Matsui, Masashi ^a   Nakanishi, Toshihiro ^a  

^a SUNTORY LTD   (Japan)

Author keywords

Anaphylactic shock; PAF (platelet activating factor); PAF acetylhydrolase

Indexed keywords

BOVINE SERUM ALBUMIN; MARKER; MYELOPEROXIDASE; RECOMBINANT ENZYME; THROMBOCYTE ACTIVATING FACTOR;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEATH; DOSE RESPONSE; ENZYME ACTIVITY; IMMUNIZATION; LUNG; MALE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANAPHYLAXIS; ANIMALS; DEATH, SUDDEN; HUMANS; LUNG; MALE; MICE; MICE, INBRED ICR; PEROXIDASE; PHOSPHOLIPASES A; PLATELET ACTIVATING FACTOR; RECOMBINANT PROTEINS;

EID: 0034712017     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00920-6     Document Type: Article

References (22)

1. Adachi T., Aoki J., Manya H., Asou H., Arai H., Inoue K. PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells. Neurosci. Lett. 235:1997;133-136.
2. Arimura A., Harada M. Differential effect of a PAF receptor antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains. Lipids. 26:1991;1386-1390.
3. Blank M.L., Lee T., Fitzgerald V., Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J. Biol. Chem. 256:1981;175-178.
4. Bozeman P.M., Learn D.B., Thomas E.L. Assay of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. J. Immunol. Methods. 126:1990;125-133.
5. Chand N. FPL 55712 - an antagonist of slow reacting substance of anaphylaxis (SRS-A): a review. Agents Actions. 9:1979;133-140.
6. Hattori M., Adachi H., Aoki J., Tsujimoto M., Arai H., Inoue K. Cloning and expression of a cDNA encoding the beta-subunit (30-kDa subunit) of bovine brain platelet-activating factor acetylhydrolase. J. Biol. Chem. 270:1995;31345-31352.
7. Hattori K., Adachi H., Matsuzawa A., Yamamoto K., Tsujimoto M., Aoki J., Hattori M., Arai H., Inoue K. cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase: II. Its homology with plasma PAF acetylhydrolase. J. Biol. Chem. 271:1996;33032-33038.
8. Hattori M., Adachi H., Tsujimoto M., Arai H., Inoue K. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase. Nature. 370:1994;216-218.
9. Herbert J.M., Lespy L., Maffrand J.P. Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice. Eur. J. Pharmacol. 205:1991;271-276.
10. Hofbauer B., Saluja A.K., Bhatia M., Frossard J.L., Lee H.S., Bhagat L., Steer M.L. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis. Gastroenterology. 115:1998;1238-1247.
11. Imaizumi T.A., Stafforini D.M., Yamada Y., McIntyre T.M., Prescott S.M., Zimmerman G.A. Platelet-activating factor: a mediator for clinicians. J. Intern. Med. 238:1995;5-20.
12. Imanishi N., Murakami-Uchida M., Koike H., Natsume Y., Morooka S. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride. Arzneimittelforschung. 44:1994;317-322.
13. Ishii S., Kuwaki T., Nagase T., Maki K., Tashiro F., Sunaga S., Cao W.H., Kume K., Fukuchi Y., Ikuta K., Miyazaki J., Kumada M., Shimizu T. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J. Exp. Med. 187:1998;1779-1788.
14. Mueller H.W., O'Flaherty J.T., Wykle R.L. The molecular species distribution of platelet-activating factor synthesized by rabbit and human neutrophils. J. Biol. Chem. 259:1984;14554-14559.
15. Myers A.K., Nakanishi T., Ramwell P. Antagonism of PAF-induced death in mice. Prostaglandins. 35:1988;447-458.
16. Pinckard R.N., Farr R.S., Hanahan D.J. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J. Immunol. 123:1979;1847-1857.
17. Sheffer A.L. Anaphylaxis. J. Allergy Clin. Immunol. 75:1985;227-233.
18. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim. Biophys. Acta. 1254:1995;231-249.
19. Stafforini D.M., Tjoelker L.W., McCormick S.P., Vaitkus D., McIntyre T.M., Gray P.W., Young S.G., Prescott S.M. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J. Biol. Chem. 274:1999;7018-7024.
20. Svetlov S.I., Howard K.M., Miwa M., Flickinger B.D., Olson M.S. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation. Arch. Biochem. Biophys. 327:1996;113-122.
21. Terashita Z., Imura Y., Shino A., Nishikawa K. A lethal role of platelet activating factor in anaphylactic shock in mice. J. Pharmacol. Exp. Ther. 243:1987;378-383.
22. Tjoelker L.W., Wilder C., Eberhardt C., Stafforini D.M., Dietsch G., Schimpf B., Hooper S., Le Trong H., Cousens L.S., Zimmerman G.A., Yamada Y., McIntyre T.M., Prescott S.M., Gray P.M. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature. 374:1995;549-553.